AzTrials
AzTrials

Kangaroo-Mother CareNCT06707376

Early Kangaroo Care vs. Standard Neonatal Practices: Impact on Survival and Outcomes in Preterm Infants

A study testing Early Kangaroo Mother Care in people with Kangaroo-Mother Care and Preterm Infants, run by Jouf University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the efficacy of Early Kangaroo Mother Care (KMC) compared to standard neonatal nursing practices in improving survival rates and nursing outcomes among preterm infants weighing less than 2000 grams with mild to moderate respiratory distress. Read more about this study

Who is it for?
Ages 28 to 36 weeks
Conditions the study is for
Kangaroo-Mother Care, Preterm Infants
What is being tested?
Early Kangaroo Mother Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
1 siteEgypt
Study dates
1 Jan 2023to 1 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 28 to 36 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Preterm infants born at <37 weeks of gestation.
  • Birth weight <2000 grams.
  • Diagnosed with mild to moderate respiratory distress (based on clinical criteria such as respiratory rate, oxygen saturation levels, and need for respiratory support).

Who cannot join

  • Infants with severe respiratory distress requiring mechanical ventilation.
  • Infants with congenital anomalies or other significant health issues.
  • Mothers unable or unwilling to provide KMC (e.g., due to medical conditions, lack of willingness).

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tanta University Hospital T

    Tanta, Gharbia Governorate, 2014

Other trials in Egypt

About this study

Official title: Early Kangaroo Mother Care Versus Standard Neonatal Nursing Practices: A Randomized Controlled Trial on Survival and Nursing Outcomes in Preterm Infants (<2000 g) With Mild to Moderate Respiratory Distress

This study aims to evaluate the efficacy of Early Kangaroo Mother Care (KMC) compared to standard neonatal nursing practices in improving survival rates and nursing outcomes among preterm infants weighing less than 2000 grams with mild to moderate respiratory distress. Utilizing a randomized controlled trial design, the research will be conducted in neonatal intensive care units (NICUs) across selected hospitals. Primary outcomes include infant survival rates, incidence of complications, and measures of maternal-infant bonding. Secondary outcomes involve nursing practices, caregiver satisfaction, and long-term developmental milestones. The use of validated, free assessment tools will ensure reliability and accessibility. Findings from this study are expected to inform best practices in neonatal care, potentially leading to improved health outcomes for preterm infants.

Read the detailed description

Preterm birth, defined as delivery before 37 weeks of gestation, is a leading cause of neonatal morbidity and mortality worldwide. Infants weighing less than 2000 grams are particularly vulnerable to complications, including respiratory distress syndrome (RDS), which can significantly impact survival rates and long-term development. Traditional neonatal nursing practices focus on providing respiratory support, maintaining body temperature, and ensuring adequate nutrition. However, emerging evidence suggests that Kangaroo Mother Care (KMC), which emphasizes skin-to-skin contact and exclusive breastfeeding, may offer superior outcomes for preterm infants.

Kangaroo Mother Care (KMC) KMC involves continuous skin-to-skin contact between the mother and infant, promoting thermal regulation, enhancing breastfeeding, and fostering maternal-infant bonding. Studies have indicated that KMC can reduce mortality rates, lower the incidence of infections, and improve neurodevelopmental outcomes. Despite its benefits, the implementation of KMC varies across healthcare settings, and its comparative effectiveness against standard neonatal care practices warrants further investigation.

Objectives

  • To compare the survival rates of preterm infants (<2000 g) with mild to moderate respiratory distress receiving early KMC versus standard neonatal nursing practices.
  • To evaluate the impact of early KMC on nursing outcomes, including maternal-infant bonding and breastfeeding rates.
  • To assess the feasibility and acceptability of implementing early KMC in NICUs.
Being tested
Early Kangaroo Mother Care
Keywords
Kangaroo-Mother Care, Neonatal Nursing Practices, Preterm Infants

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Kangaroo Mother CareOther

    • Initiation of KMC within 24 hours of birth.
    • Continuous skin-to-skin contact for at least 8 hours per day, with gradual increase based on infant tolerance.
    • Support for exclusive breastfeeding or expressed breast milk feeding.
    • Ongoing assessment and support from trained neonatal nurses and lactation consultants.
Study groups in NCT06707376
Study groupRoleWhat they receive
Early Kangaroo Mother Care GroupExperimentalEarly Kangaroo Mother Care Group: * Initiation of KMC within 24 hours of birth. * Continuous skin-to-skin contact for at least 8 hours per day, with gradual increase based on infant tolerance. * Support for exclusive breastfeeding or expressed breast milk feeding. * Ongoing assessment and support from trained neonatal nurses and lactation consultants.
Receives: Other: Early Kangaroo Mother Care
Control GroupNo interventionControl Group: * Standard neonatal nursing practices, including incubator care, intermittent holding, and feeding as per clinical guidelines. * Respiratory support as needed based on the severity of respiratory distress.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival Rates

    Survival Rates will be the proportion of preterm infants who survive following the implementation of KMC, a practice emphasizing continuous skin-to-skin contact and exclusive breastfeeding.

    For infants weighing less than 2000 grams, KMC has been associated with reduced mortality, particularly in low-resource settings where conventional neonatal care may be limited. By promoting physiological stability, enhancing maternal bonding, and reducing the risk of severe complications like infections and hypothermia, KMC offers a cost-effective and impactful approach to improving survival outcomes in this vulnerable population.

    Measured: Up to 24 weeks

  2. Incidence of Complications

    Incidence of Complications Including infections, intraventricular hemorrhage, and necrotizing enterocolitis.

    Measured: Up to 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2024
  2. Study start1 Jan 2023
  3. Primary completion30 Jun 2024
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Early Kangaroo Mother Care Group: * Initiation of KMC within 24 hours of birth. * Continuous skin-to-skin contact for at least 8 hours per day, with gradual increase based on infant tolerance. * Support for exclusive breastfeeding or expressed breast milk feeding. * Ongoing assessment and support from trained neonatal nurses and lactation consultants. Control Group: * Standard neonatal nursing practices, including incubator care, intermittent holding, and feeding as per clinical guidelines. * Respiratory support as needed based on the severity of respiratory distress.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06707376
Sponsor's protocol ID
547-10-2024
Status last verified
Feb 2025
First submitted
20 Nov 2024
Last updated
25 Feb 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ramadan OME, Alshammari AM, Alruwaili AN, Elsharkawy NB, Alhaiti A, Baraka NIM. Transforming neonatal nursing: a randomized controlled trial comparing kangaroo care and standard protocols for survival in preterm infants with respiratory distress syndrome. BMC Nurs. 2025 Apr 16;24(1):430. doi: 10.1186/s12912-025-03088-8.

    PubMed 40241073

Questions about this trial

What is this clinical trial studying?

A study testing Early Kangaroo Mother Care in people with Kangaroo-Mother Care and Preterm Infants, run by Jouf University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival Rates (time frame: Up to 24 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06707376, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in